• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24657
Device Problems Break (1069); Difficult to Remove (1528); Difficult to Advance (2920)
Patient Problem Foreign Body In Patient (2687)
Event Date 04/20/2023
Event Type  Injury  
Event Description
It was reported that the catheter of the delivery system became stuck on the stent, and both the stent and catheter tip broke off within the patient.An endarterectomy was performed to remove the stent and catheter fragments.A 6x80, 130 cm eluvia drug-eluting vascular stent system was selected for use in the procedure.The target lesion was located in the superficial femoral artery (sfa) and was reported to have both moderate tortuosity and calcification.When advancing the delivery system to the target lesion, there was resistance noted.When the stent was fully deployed, it would not release from the catheter.The catheter of the delivery system became stuck on the stent, and both the stent and catheter tip broke off within the patient.An endarterectomy was performed to remove the stent and fragment of the catheter.The stent was fully intact until it was retrieved.It was unknown whether any device fragments remained within the patient.There were no further adverse consequences reported for the patient post procedure.The patient's status was ok.
 
Manufacturer Narrative
Device analysis: returned product consisted of an eluvia self-expanding stent system with an unknown 0.035in hydrophilic guidewire stuck inside the device.The outer sheath, tip, inner sheath, and the remainder of the device were checked for damage.Visual examination revealed that the handle was partially open.The pull rack was separated at the handle.The proximal section of the pull rack was missing.The inner liner was kinked at the distal end of the proximal inner and 1cm from the distal end of the proximal inner.The inner liner was separated 22mm from the tip.The stent returned damaged and in four pieces.With the pieces lined up, it measured less than 70mm.Both ends of the radiopaque markers were present.Microscopic examination revealed no additional damages.The handle was x-rayed, and no additional damages were found.Inspection of the remainder of the device revealed no other damage or irregularities.Product analysis found damage that would have contributed to the reported event.
 
Event Description
It was reported that the catheter of the delivery system became stuck on the stent, and both the stent and catheter tip broke off within the patient.An endarterectomy was performed to remove the stent and catheter fragments.A 6x80, 130 cm eluvia drug-eluting vascular stent system was selected for use in the procedure.The target lesion was located in the superficial femoral artery (sfa) and was reported to have both moderate tortuosity and calcification.When advancing the delivery system to the target lesion, there was resistance noted.When the stent was fully deployed, it would not release from the catheter.The catheter of the delivery system became stuck on the stent, and both the stent and catheter tip broke off within the patient.An endarterectomy was performed to remove the stent and fragment of the catheter.The stent was fully intact until it was retrieved.It was unknown whether any device fragments remained within the patient.There were no further adverse consequences reported for the patient post procedure.The patient's status was ok.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jeff wallner
4100 hamline ave n
arden hills, MN 55112
6515811560
MDR Report Key16953630
MDR Text Key315473455
Report Number2124215-2023-24316
Device Sequence Number1
Product Code NIU
UDI-Device Identifier08714729876595
UDI-Public08714729876595
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/18/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/29/2023
Device Model Number24657
Device Catalogue Number24657
Device Lot Number0028307257
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/12/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/24/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/29/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-